Comparison of the effectiveness of medicinal and non-medicinal therapy on the control of nocturnal enuresis of children

Comparison of the effectiveness of medicinal(desmopressin) and non-medicinal(alarm) therapy on the control of nocturnal enuresis of children

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180428039453N1

Enrollment

Registered

2018-07-09

Start date

2017-09-23

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urinary incontinence. Functional urinary incontinence

Interventions

Intervention 1: Control group: This group contain of 10 patients will use desmopressin spray with the traditional name of desmex that made in iran, and the dosage will be used every night (one puff pe

Eligibility

Sex/Gender

All

Age

6 Years to 18 Years

Inclusion criteria

Inclusion criteria: children with primary enuresis with 6 to 18 years old completion of informed consent form no existence of urological diseases

Exclusion criteria

Exclusion criteria: patients with neurogenic bladder congenital disorders of urinary system urinary tract obstruction neurological disorders such as myelomenoncule unwillingness to participate in the study

Design outcomes

Primary

Measure	Time frame
Rate of control and improvement of incontinence after use of enuresis alarm vs desmopressin. Timepoint: A month after use of enuresis alarm. Method of measurement: The therapeutic response will be divided into three levels more effectively and without any difference and less effect.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAnoosh Azarfar

Mashhad University of Medical Sciences

azarfara@mums.ac.ir+98 51 3726 9021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026